Cargando…
CT findings in survivors and non-survivors of COVID-19 and clinical usefulness of a CT scoring system()
BACKGROUND: Many patients with coronavirus disease 2019 (COVID-19) have been diagnosed with computed tomography (CT). A prognostic tool based on CT findings could be useful for predicting death from COVID-19. OBJECTIVES: To compare the chest CT findings of patients who survived COVID-19 versus those...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SERAM. Published by Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845416/ https://www.ncbi.nlm.nih.gov/pubmed/35180982 http://dx.doi.org/10.1016/j.rxeng.2021.09.003 |
_version_ | 1784651671638376448 |
---|---|
author | Collado-Chagoya, R. Hernández-Chavero, H. Ordinola Navarro, A. Castillo-Castillo, D. Quiroz-Meléndez, J.G. González-Veyrand, E. López Luis, B.A. |
author_facet | Collado-Chagoya, R. Hernández-Chavero, H. Ordinola Navarro, A. Castillo-Castillo, D. Quiroz-Meléndez, J.G. González-Veyrand, E. López Luis, B.A. |
author_sort | Collado-Chagoya, R. |
collection | PubMed |
description | BACKGROUND: Many patients with coronavirus disease 2019 (COVID-19) have been diagnosed with computed tomography (CT). A prognostic tool based on CT findings could be useful for predicting death from COVID-19. OBJECTIVES: To compare the chest CT findings of patients who survived COVID-19 versus those of patients who died of COVID-19 and to determine the usefulness the clinical usefulness of a CT scoring system for COVID-19. METHODS: We included 124 patients with confirmed SARS-CoV-2 infections who were hospitalized between April 1, 2020 and July 25, 2020. RESULTS: Whereas ground-glass opacities were the most common characteristic finding in survivors (75%), crazy paving was the most characteristic finding in non-survivors (65%). Atypical findings were present in 46% of patients. The chest CT score was directly proportional to mortality; a score ≥18 was the best cutoff for predicting death, yielding 70% sensitivity (95%CI: 47%–87%). CONCLUSIONS: Our results suggest that atypical lesions are more prevalent in this cohort. The chest CT score had high sensitivity for predicting hospital mortality. |
format | Online Article Text |
id | pubmed-8845416 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SERAM. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88454162022-02-15 CT findings in survivors and non-survivors of COVID-19 and clinical usefulness of a CT scoring system() Collado-Chagoya, R. Hernández-Chavero, H. Ordinola Navarro, A. Castillo-Castillo, D. Quiroz-Meléndez, J.G. González-Veyrand, E. López Luis, B.A. Radiologia (Engl Ed) Original Articles BACKGROUND: Many patients with coronavirus disease 2019 (COVID-19) have been diagnosed with computed tomography (CT). A prognostic tool based on CT findings could be useful for predicting death from COVID-19. OBJECTIVES: To compare the chest CT findings of patients who survived COVID-19 versus those of patients who died of COVID-19 and to determine the usefulness the clinical usefulness of a CT scoring system for COVID-19. METHODS: We included 124 patients with confirmed SARS-CoV-2 infections who were hospitalized between April 1, 2020 and July 25, 2020. RESULTS: Whereas ground-glass opacities were the most common characteristic finding in survivors (75%), crazy paving was the most characteristic finding in non-survivors (65%). Atypical findings were present in 46% of patients. The chest CT score was directly proportional to mortality; a score ≥18 was the best cutoff for predicting death, yielding 70% sensitivity (95%CI: 47%–87%). CONCLUSIONS: Our results suggest that atypical lesions are more prevalent in this cohort. The chest CT score had high sensitivity for predicting hospital mortality. SERAM. Published by Elsevier España, S.L.U. 2022 2022-02-15 /pmc/articles/PMC8845416/ /pubmed/35180982 http://dx.doi.org/10.1016/j.rxeng.2021.09.003 Text en © 2021 SERAM. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Articles Collado-Chagoya, R. Hernández-Chavero, H. Ordinola Navarro, A. Castillo-Castillo, D. Quiroz-Meléndez, J.G. González-Veyrand, E. López Luis, B.A. CT findings in survivors and non-survivors of COVID-19 and clinical usefulness of a CT scoring system() |
title | CT findings in survivors and non-survivors of COVID-19 and clinical usefulness of a CT scoring system() |
title_full | CT findings in survivors and non-survivors of COVID-19 and clinical usefulness of a CT scoring system() |
title_fullStr | CT findings in survivors and non-survivors of COVID-19 and clinical usefulness of a CT scoring system() |
title_full_unstemmed | CT findings in survivors and non-survivors of COVID-19 and clinical usefulness of a CT scoring system() |
title_short | CT findings in survivors and non-survivors of COVID-19 and clinical usefulness of a CT scoring system() |
title_sort | ct findings in survivors and non-survivors of covid-19 and clinical usefulness of a ct scoring system() |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845416/ https://www.ncbi.nlm.nih.gov/pubmed/35180982 http://dx.doi.org/10.1016/j.rxeng.2021.09.003 |
work_keys_str_mv | AT colladochagoyar ctfindingsinsurvivorsandnonsurvivorsofcovid19andclinicalusefulnessofactscoringsystem AT hernandezchaveroh ctfindingsinsurvivorsandnonsurvivorsofcovid19andclinicalusefulnessofactscoringsystem AT ordinolanavarroa ctfindingsinsurvivorsandnonsurvivorsofcovid19andclinicalusefulnessofactscoringsystem AT castillocastillod ctfindingsinsurvivorsandnonsurvivorsofcovid19andclinicalusefulnessofactscoringsystem AT quirozmelendezjg ctfindingsinsurvivorsandnonsurvivorsofcovid19andclinicalusefulnessofactscoringsystem AT gonzalezveyrande ctfindingsinsurvivorsandnonsurvivorsofcovid19andclinicalusefulnessofactscoringsystem AT lopezluisba ctfindingsinsurvivorsandnonsurvivorsofcovid19andclinicalusefulnessofactscoringsystem |